A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...

Shipping group A.P. Moller-Maersk warned on Thursday that a global trade war and geopolitical uncertainty could trigger a ...

Recent actions by President Donald Trump's administration, including staff cuts at the Food and Drug Administration, have ...

Federal health agencies will create a database of autism patients enrolled in Medicare and Medicaid that researchers will use ...

Following a similar decision in case the trade group Outsourcing Facilities Association brought against FDA over its decision to declare the end of the shortage of Novo Nordisk’s semaglutide, Judge ...

Sales are booming for Lilly's tirzepatide products, Mounjaro and Zepbound. The company's market share for incretin analogs now tops 50%. Notably, Lilly's market share is increasing while Novo ...

Pharmaceutical company Charles River Laboratories has reached a settlement with activist investor Elliott Investment ...

(Reuters) -European shares ended lower on Wednesday, pausing after weeks of strong gains, while investors monitored a raft of ...

It was spurred by the Intercept’s disclosure of Musk’s hitherto-secret White House email address: [email protected]. When the Intercept first published Musk’s email address, on March 6, journalist ...

EUROPEAN shares ended lower on Wednesday, pausing after weeks of strong gains, while investors monitored a raft of corporate ...

In advance of the Bank of England’s rates decision on Thursday, UK lenders Barclays and NatWest were down by 0.6 per cent and ...

Shares rallied Wednesday even after the drugmaker lowered its full-year guidance as alternative versions of its blockbuster ...